TC Biopharm (Holdings) Plc (TCBPY)
OTCMKTS
· Delayed Price · Currency is USD
0.3000
-0.0200 (-6.25%)
Apr 2, 2025, 9:30 AM EST
TC Biopharm (Holdings) Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
41
Market Cap
123.12K USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 3.84M | 1.87M | 94.30% |
| Dec 31, 2021 | 1.98M | - | - |
| Dec 31, 2020 | 1.98M | -1.45M | -42.26% |
| Dec 31, 2019 | 3.43M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| American Oncology Network | 1.76B |
| Longduoduo Company | 6.01M |
TC Biopharm (Holdings) News
- 13 days ago - TCBP Announces Transition from Nasdaq to OTC Markets - PRNewsWire
- 16 days ago - TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead - PRNewsWire
- 4 weeks ago - TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - PRNewsWire
- 6 weeks ago - TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum - PRNewsWire
- 7 weeks ago - TCBP Announces Successful Completion of Cohort A in the ACHIEVE Clinical Trial - PRNewsWire
- 7 weeks ago - TCBP Announces Successful Completion of Initial Cohort B Patient Dosing in the ACHIEVE Clinical Trial - PRNewsWire
- 2 months ago - TCBP to Implement ADS Ratio Change - PRNewsWire
- 2 months ago - TCBP Announces H5N1 Proof of Concept Studies Intention - PRNewsWire